References
- LiuF-TRabinovichGAGalectins: regulators of acute and chronic inflammationAnn N Y Acad Sci2010118315818220146714
- GiordanoMCrociDORabinovichGAGalectins in hematological malignanciesCurr Opin Hematol201320432733523695449
- RabinovichGAVidalMGalectins and microenvironmental niches during hematopoiesisCurr Opin Hematol201118644345121912250
- BarrionuevoPBeigier-BompadreMIlarreguiJMA novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathwayJ Immunol20061781436445
- YangRYRabinovichGALiuFTGalectins: structure, function and therapeutic potentialExpert Rev Mol Med200810e1718549522
- RubinsteinNAlvarezMZwirnerNWTargeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejectionCancer Cell20045324125115050916
- ToscanoMABiancoGAIlarreguiJMDifferential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell deathNat Immunol20078882583417589510
- KamperPLudvigsenMBendixKProteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphomaBlood2011117246638664921505194
- OuyangJPlütschowAPogge von StrandmannEGalectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphomaBlood2013121173431343323444403
- PetruskeviciusILudvigsenMHjortebjergRClinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantationBone Marrow Transplant201651101387139027214079
- CrociDOMorandePEDergan-DylonSNurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1Leukemia20132761413141623257714
- KyleRASteensmaDPHistory of multiple myelomaRecent Results Cancer Res201118332321509678
- ZhengYYangJQianJPSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myelomaLeukemia201227370271022996336
- SuyanıESucakGTAkyürekNTumor-associated macrophages as a prognostic parameter in multiple myelomaAnn Hematol201392566967723334187
- PanchabhaiSKelemenKAhmannGSebastianSManteiJFonsecaRTumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myelomaLeukemia201630495195426202926
- AbrounSOtsuyamaK-IShamsasenjanKGalectin-1 supports the survival of CD45RA(−) primary myeloma cells in vitroBr J Haematol2008142575476518537967
- StortiPMarchicaVAiroldiIGalectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivoLeukemia201630122351236327311934
- AndersenNFStandalTNielsenJLSyndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survivalBr J Haematol2005128221021715638855
- GriffioenAWThijssenVLGalectins in tumor angiogenesisAnn Transl Med2014299025405165
- AndersenMNAbildgaardNManieckiMBMøllerHJAndersenNFMonocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myelomaEur J Haematol2014931414724612259
- AndersenMNAndersenNFRødgaard-HansenSHoklandMAbildgaardNMøllerHJThe novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): implications in multiple myelomaLeuk Res201539997197526169445
- GreippPRSan MiguelJDurieBGMInternational staging system for multiple myelomaJ Clin Oncol200523153412342015809451
- SicaAAllavenaPMantovaniACancer related inflammation: the macrophage connectionCancer Lett2008267220421518448242